Literature DB >> 3807504

[Indications and surgical results in asymptomatic stenosis of the carotid artery].

F M Grögler, J Knippschild, H J Büdingen.   

Abstract

In 101 patients 114 asymptomatic carotid stenoses were treated operatively, complicated by one lesion of hypoglossic nerve and one temporary neurologic deficit. During the follow-up period of 6-89 months cardiovascular diseases were seen in 60% of the patients. There were 9 late deaths, 5 due to myocardial infarction and 2 due to contrahemispheric cerebral ischemia. TIA's or cerebral infarctions were not observed in the hemisphere corresponding to the operated carotid artery. Interdisciplinary patient selection, non-invasive diagnostics and selective shunt protection are considered to be essential risk reducing factors.

Entities:  

Mesh:

Year:  1986        PMID: 3807504     DOI: 10.1007/bf01274332

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  5 in total

1.  Stroke risk from symptomless extracranial arterial disease.

Authors:  M Hennerici; W Rautenberg; S Mohr
Journal:  Lancet       Date:  1982-11-27       Impact factor: 79.321

2.  Carotid endarterectomy: a follow-up study of the contralateral non-operated carotid artery.

Authors:  N Johnson; S J Burnham; D P Flanigan; J J Goodreau; J S Yao; J J Bergan
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

3.  Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries.

Authors:  R Aaslid; T M Markwalder; H Nornes
Journal:  J Neurosurg       Date:  1982-12       Impact factor: 5.115

4.  Bilateral occlusive carotid disease: simultaneous or staged operation?

Authors:  F M Grögler; K Pfadenhauer; H J Reulen; H J Büdingen
Journal:  Thorac Cardiovasc Surg       Date:  1984-02       Impact factor: 1.827

5.  Asymptomatic carotid stenosis. Immediate and long-term results after prophylactic endarterectomy.

Authors:  W S Moore; C Boren; J M Malone; J Goldstone
Journal:  Am J Surg       Date:  1979-08       Impact factor: 2.565

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.